Your browser doesn't support javascript.
loading
How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
Penfornis, Alfred; Blicklé, Jean Frédéric; Fiquet, Béatrice; Quéré, Stéphane; Dejager, Sylvie.
Afiliação
  • Penfornis A; Department of Endocrinology-Metabolism and Diabetology-Nutrition, Jean Minjoz Hospital, University of Franche-Comté, Besançon, France.
  • Blicklé JF; Department of Internal Medicine and Diabetology, Strasbourg University Hospital, Strasbourg, France.
  • Fiquet B; Clinical Affairs, Novartis Pharma SAS, Rueil-Malmaison, France.
  • Quéré S; BioStatistics, Novartis Pharma SAS, Rueil-Malmaison, France.
  • Dejager S; Clinical Affairs, Novartis Pharma SAS, Rueil-Malmaison, France.
Vasc Health Risk Manag ; 10: 341-52, 2014.
Article em En | MEDLINE | ID: mdl-24966684

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Hipoglicemiantes / Metformina Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal Crônica / Hipoglicemiantes / Metformina Idioma: En Ano de publicação: 2014 Tipo de documento: Article